Clinical Trials Browser

OTHER × Stage II Prostate Adenocarcinoma × Clear all

NCT02949284 2026-01-07

Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery

Phase 2 Active not recruiting

Stage II Prostate Adenocarcinoma

NCT03113617 2023-12-12

68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer

Phase 2 Completed

44 enrolled 8 charts

Stage II Prostate Adenocarcinoma

NCT02678351 2022-03-04

68Ga-PSMA-11 PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing Surgery

Phase 2/3 Completed

74 enrolled 9 charts

Stage II Prostate Adenocarcinoma